Cibinqo 200 mg Cibinqo 200 mg contains abrocitinib, an oral prescription medicine used to treat moderate to severe atopic dermatitis (eczema) in patients who require systemic therapy. It works by selectively blocking the Janus Kinase 1 (JAK1) pathway, which is involved in the body's inflammatory response. By reducing inflammation, Cibinqo helps relieve eczema symptoms and supports healthier skin over time.

Effects & Benefits Helps reduce itching associated with moderate to severe eczema. Relieves redness, swelling, and skin irritation. Helps improve the appearance and condition of affected skin. Reduces the frequency of eczema flare-ups. Supports better sleep by controlling persistent itching. Improves overall comfort and quality of life when used regularly. Possible Side Effects